BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang S, Liu Y, Li J, Zhao L, Yan W, Lin B, Guo X, Wei Y. Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality. Front Cell Dev Biol 2021;9:710165. [PMID: 34490259 DOI: 10.3389/fcell.2021.710165] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Asili P, Mirahmad M, Rezaei P, Mahdavi M, Larijani B, Tavangar SM. The Association of Oral Microbiome Dysbiosis with Gastrointestinal Cancers and Its Diagnostic Efficacy. J Gastrointest Cancer 2023. [PMID: 36600023 DOI: 10.1007/s12029-022-00901-4] [Reference Citation Analysis]
2 Thananimit S, Pahumunto N, Teanpaisan R. Characterization of Short Chain Fatty Acids Produced by Selected Potential Probiotic Lactobacillus Strains. Biomolecules 2022;12. [PMID: 36551257 DOI: 10.3390/biom12121829] [Reference Citation Analysis]
3 Abba M, Lacunza E, Fink V, Salas M, Canzoneri R, Naipauer J, Williams S, Coso O, Sued O, Cahn P, Mesri E. Oral and anal microbiome from HIV-exposed individuals: role of host-associated factors in taxa composition and metabolic pathways.. [DOI: 10.21203/rs.3.rs-2302824/v1] [Reference Citation Analysis]
4 Pal S, Saini AK, Kaushal A, Gupta S, Gaur NA, Chhillar AK, Sharma AK, Gupta VK, Saini RV. The Colloquy between Microbiota and the Immune System in Colon Cancer: Repercussions on the Cancer Therapy. Curr Pharm Des 2022;28:3478-85. [PMID: 36415093 DOI: 10.2174/1381612829666221122115906] [Reference Citation Analysis]
5 Livyatan I, Straussman R. A spatial perspective on bacteria in tumours. Nature 2022. [DOI: 10.1038/d41586-022-03669-6] [Reference Citation Analysis]
6 Alrahawy M, Javed S, Atif H, Elsanhoury K, Mekhaeil K, Eskander G. Microbiome and Colorectal Cancer Management. Cureus 2022. [DOI: 10.7759/cureus.30720] [Reference Citation Analysis]
7 Zundler S, Mardin C, Bertz S, Vitali F, Strauß R, Fürst J, Neurath MF, Strobel D. Rectal Cancer Presenting with Absceding Infection Due to Fusobacterium nucleatum. Pathogens 2022;11:1113. [DOI: 10.3390/pathogens11101113] [Reference Citation Analysis]
8 Zaura E. A Commentary on the Potential Use of Oral Microbiome in Prediction, Diagnosis or Prognostics of a Distant Pathology. Dentistry Journal 2022;10:156. [DOI: 10.3390/dj10090156] [Reference Citation Analysis]
9 Kong C, Liang L, Liu G, Du L, Yang Y, Liu J, Shi D, Li X, Ma Y. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer. Gut 2022:gutjnl-2022-327156. [PMID: 35953094 DOI: 10.1136/gutjnl-2022-327156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Valdovinos-diaz M. Fusobacterium nucleatum en el carcinoma colorrectal: ¿asociación o causalidad? Revista de Gastroenterología de México 2022;87:275-276. [DOI: 10.1016/j.rgmx.2022.01.005] [Reference Citation Analysis]
11 Chen W, Zhang X, Zhang Y, Yue C, Wang Y, Pan H, Zhang Y, Liu H, Zhang Y. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer. CURR MED SCI 2022;42:538-547. [DOI: 10.1007/s11596-022-2597-1] [Reference Citation Analysis]
12 Valdovinos-Díaz MÁ. Fusobacterium nucleatum in colorectal cancer: Association or causality? Rev Gastroenterol Mex (Engl Ed) 2022:S2255-534X(22)00034-2. [PMID: 35623988 DOI: 10.1016/j.rgmxen.2022.01.003] [Reference Citation Analysis]
13 Wang H, Zhang K, Wu L, Qin Q, He Y. Prediction of Pathogenic Factors in Dysbiotic Gut Microbiomes of Colorectal Cancer Patients Using Reverse Microbiomics. Front Oncol 2022;12:882874. [PMID: 35574378 DOI: 10.3389/fonc.2022.882874] [Reference Citation Analysis]
14 Dokht Khosravi A, Seyed-Mohammadi S, Teimoori A, Asarehzadegan Dezfuli A. The role of microbiota in colorectal cancer. Folia Microbiol (Praha) 2022. [PMID: 35534716 DOI: 10.1007/s12223-022-00978-1] [Reference Citation Analysis]
15 Zhang X, Zhang Y, Gui X, Zhang Y, Zhang Z, Chen W, Zhang X, Wang Y, Zhang M, Shang Z, Xin Y, Zhang Y. Salivary Fusobacterium nucleatum serves as a potential biomarker for colorectal cancer. iScience 2022;25:104203. [DOI: 10.1016/j.isci.2022.104203] [Reference Citation Analysis]
16 Bai H, Yang J, Meng S, Liu C. Oral Microbiota-Driven Cell Migration in Carcinogenesis and Metastasis. Front Cell Infect Microbiol 2022;12:864479. [DOI: 10.3389/fcimb.2022.864479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Al-Ishaq RK, Koklesova L, Kubatka P, Büsselberg D. Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer. Cancers (Basel) 2022;14:2140. [PMID: 35565269 DOI: 10.3390/cancers14092140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Li Y, Zhang F, Zheng H, Kalasabail S, Hicks C, Fung KY, Preaudet A, Putoczki T, Beretov J, Millar EKA, El-omar E, Jiang X, Yim HCH. Fecal DNA Virome Is Associated with the Development of Colorectal Neoplasia in a Murine Model of Colorectal Cancer. Pathogens 2022;11:457. [DOI: 10.3390/pathogens11040457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhou P, Yang D, Sun D, Zhou Y. Gut microbiome: New biomarkers in early screening of colorectal cancer. Clinical Laboratory Analysis. [DOI: 10.1002/jcla.24359] [Reference Citation Analysis]
20 Peng X, Cheng L, You Y, Tang C, Ren B, Li Y, Xu X, Zhou X. Oral microbiota in human systematic diseases. Int J Oral Sci 2022;14:14. [PMID: 35236828 DOI: 10.1038/s41368-022-00163-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 26.0] [Reference Citation Analysis]
21 Li J, Zhang AH, Wu FF, Wang XJ. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects. Front Oncol 2022;12:841552. [PMID: 35223525 DOI: 10.3389/fonc.2022.841552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
22 Liu Y, He W, Yang J, He Y, Wang Z, Li K. The effects of preoperative intestinal dysbacteriosis on postoperative recovery in colorectal cancer surgery: a prospective cohort study. BMC Gastroenterol 2021;21:446. [PMID: 34823504 DOI: 10.1186/s12876-021-02035-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]